Debio 4228
/ Debiopharm
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
July 28, 2026
Debio 4228-201: A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
(clinicaltrials.gov)
- P2 | N=55 | Completed | Sponsor: Debiopharm International SA | Active, not recruiting ➔ Completed
Trial completion • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
May 29, 2026
Debio 4228-201: A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
(clinicaltrials.gov)
- P2 | N=55 | Active, not recruiting | Sponsor: Debiopharm International SA | Trial primary completion date: Dec 2026 ➔ Jun 2026 | Trial completion date: Jan 2027 ➔ Jul 2026
Trial completion date • Trial primary completion date • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
March 31, 2026
Debio 4228-201: A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
(clinicaltrials.gov)
- P2 | N=66 | Active, not recruiting | Sponsor: Debiopharm International SA | Recruiting ➔ Active, not recruiting
Enrollment closed • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
May 31, 2025
Debio 4228-201: A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
(clinicaltrials.gov)
- P2 | N=66 | Recruiting | Sponsor: Debiopharm International SA | Trial completion date: Apr 2026 ➔ Jan 2027 | Trial primary completion date: Mar 2026 ➔ Dec 2026
Trial completion date • Trial primary completion date • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
May 28, 2024
Debio 4228-201: A Dose Finding Study of Debio 4228 in Participants With Locally Advanced/Metastatic Prostate Cancer
(clinicaltrials.gov)
- P2 | N=60 | Recruiting | Sponsor: Debiopharm International SA | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
May 02, 2024
A Dose Finding Study of Debio 4228 in Participants With Locally Advanced/Metastatic Prostate Cancer
(clinicaltrials.gov)
- P2 | N=60 | Not yet recruiting | Sponsor: Debiopharm International SA
Metastases • New P2 trial • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
1 to 6
Of
6
Go to page
1